logo

Array Biopharma Inc. (ARRY)



Trade ARRY now with
  Date
  Headline
5/9/2018 8:03:44 AM Array BioPharma Q3 Loss Per Share $0.11 Vs Loss $0.21 Last Year
3/22/2018 9:02:23 AM Array BioPharma Announces Publication Of Detailed Phase 3 COLUMBUS Trial Data Of Encorafenib And Binimetinib
2/6/2018 8:07:37 AM Array BioPharma Q2 Total Revenue $42.2 Mln Vs. $44.5 Mln Last Year
2/6/2018 8:04:58 AM Array BioPharma And Pierre Fabre Report Results Of Planned Analysis Of OS From Pivotal Phase 3 COLUMBUS Trial
1/20/2018 8:23:11 PM Array BioPharma, Pierre Fabre Reveal Updated Results From BEACON CRC Trial
1/16/2018 8:05:07 AM Array BioPharma To Present Updated Phase 3 BEACON CRC Safety Lead-In Results Of The Combination Of Encorafenib
12/19/2017 8:02:51 AM Array BioPharma Enters Clinical Trial Collaboration Agreement With Pfizer
11/13/2017 8:04:02 AM Array BioPharma Reports Data From Phase 1b Clinical Trial On Immunotherapy Combination Of ARRY-382 With Merck's KEYTRUDA